299 related articles for article (PubMed ID: 25623738)
1. The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
Bezan A; Mrsic E; Krieger D; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
J Urol; 2015 Jul; 194(1):30-5. PubMed ID: 25623738
[TBL] [Abstract][Full Text] [Related]
2. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
3. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.
Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
Clin Genitourin Cancer; 2017 Oct; 15(5):598-604. PubMed ID: 28495053
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
Gorgel SN; Kose O; Koc EM; Ates E; Akin Y; Yilmaz Y
Int Urol Nephrol; 2017 Sep; 49(9):1577-1583. PubMed ID: 28669104
[TBL] [Abstract][Full Text] [Related]
6. External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Rehak P; Pummer K; Zigeuner R
J Urol; 2011 Nov; 186(5):1773-7. PubMed ID: 21944989
[TBL] [Abstract][Full Text] [Related]
7. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment.
Kang M; Shin SJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
Dis Markers; 2020; 2020():8887605. PubMed ID: 32724485
[TBL] [Abstract][Full Text] [Related]
9. The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma.
Canat L; Ataly HA; Agalarov S; Alkan I; Altunrende F
Int Braz J Urol; 2018; 44(2):288-295. PubMed ID: 29211398
[TBL] [Abstract][Full Text] [Related]
10. De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.
Lee H; Choi YH; Sung HH; Han DH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Lee HM; Choi HY
Clin Genitourin Cancer; 2017 Jun; 15(3):e379-e385. PubMed ID: 27692696
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
Kang M; Yu J; Sung HH; Jeon HG; Jeong BC; Park SH; Jeon SS; Lee HM; Choi HY; Seo SI
Int J Urol; 2018 Jun; 25(6):596-603. PubMed ID: 29756394
[TBL] [Abstract][Full Text] [Related]
12. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the Leibovich prognosis score supplemented by vascular invasion for clear cell renal cell carcinoma.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Groselj-Strele A; Kampel-Kettner K; Pummer K; Zigeuner R
J Urol; 2012 Mar; 187(3):834-9. PubMed ID: 22245331
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
15. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
Dis Markers; 2019; 2019():6702964. PubMed ID: 31534562
[TBL] [Abstract][Full Text] [Related]
16. Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study.
Cheng X; Zhou X; Yi M; Xu S; Zhang C; Wang G
BMC Urol; 2021 Sep; 21(1):136. PubMed ID: 34579695
[TBL] [Abstract][Full Text] [Related]
17. Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma.
Pichler M; Dalpiaz O; Ehrlich GC; Stojakovic T; Martín Hernández JM; Mannweiler S; Pummer K; Zigeuner R; Hutterer GC
J Urol; 2014 Apr; 191(4):920-5. PubMed ID: 24513163
[TBL] [Abstract][Full Text] [Related]
18. Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.
Seles M; Posch F; Pichler GP; Gary T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
J Urol; 2017 Dec; 198(6):1247-1252. PubMed ID: 28716649
[TBL] [Abstract][Full Text] [Related]
19. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy.
Mori K; Janisch F; Mostafaei H; Kimura S; Lysenko I; Karakiewicz PI; Briganti A; Enikeev DV; Rouprêt M; Margulis V; Chlosta P; Nyirady P; Babjuk M; Egawa S; Shariat SF
Urol Oncol; 2020 Jun; 38(6):601.e17-601.e24. PubMed ID: 32127252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
